These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22768080)

  • 21. FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling.
    Xing X; Liu M; Wang X; Guo Q; Wang H; Wang W
    J Cell Mol Med; 2024 Jan; 28(1):e18041. PubMed ID: 37987202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metadherin contribute to BCR signaling in chronic lymphocytic leukemia.
    Li PP; Yao QM; Zhou H; Feng LL; Ge XL; Lv X; Chen N; Lu K; Wang X
    Int J Clin Exp Pathol; 2014; 7(4):1588-94. PubMed ID: 24817955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.
    Meng X; Zhu D; Yang S; Wang X; Xiong Z; Zhang Y; Brachova P; Leslie KK
    J Biol Chem; 2012 Feb; 287(7):4485-91. PubMed ID: 22199357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of MTDH sensitizes endometrial cancer cells to cell death induction by death receptor ligand TRAIL and HDAC inhibitor LBH589 co-treatment.
    Meng X; Brachova P; Yang S; Xiong Z; Zhang Y; Thiel KW; Leslie KK
    PLoS One; 2011; 6(6):e20920. PubMed ID: 21687633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of heme oxygenase-1 induced by constitutively activated NF-κB as a potential therapeutic target for activated B-cell-like diffuse large B-cell lymphoma.
    Huang J; Guo P; Ma D; Lin X; Fang Q; Wang J
    Int J Oncol; 2016 Jul; 49(1):253-64. PubMed ID: 27211510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long non-coding RNA HCG18 promotes the growth and invasion of colorectal cancer cells through sponging miR-1271 and upregulating MTDH/Wnt/β-catenin.
    Li S; Wu T; Zhang D; Sun X; Zhang X
    Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):703-712. PubMed ID: 31854468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.
    Zhong W; Xu X; Zhu Z; Du Q; Du H; Yang L; Ling Y; Xiong H; Li Q
    Oncotarget; 2017 Jul; 8(30):49757-49772. PubMed ID: 28537908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-433 inhibits cervical cancer progression by directly targeting metadherin to regulate the AKT and β-catenin signalling pathways.
    Liang C; Ding J; Yang Y; Deng L; Li X
    Oncol Rep; 2017 Dec; 38(6):3639-3649. PubMed ID: 29130111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metadherin regulation of vascular endothelial growth factor expression is dependent upon the PI3K/Akt pathway in squamous cell carcinoma of the head and neck.
    Zhu GC; Yu CY; She L; Tan HL; Li G; Ren SL; Su ZW; Wei M; Huang DH; Tian YQ; Su RN; Liu Y; Zhang X
    Medicine (Baltimore); 2015 Feb; 94(6):e502. PubMed ID: 25674742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of dysregulated metadherin and microRNA-375 in head and neck cancer.
    Hui AB; Bruce JP; Alajez NM; Shi W; Yue S; Perez-Ordonez B; Xu W; O'Sullivan B; Waldron J; Cummings B; Gullane P; Siu L; Liu FF
    Clin Cancer Res; 2011 Dec; 17(24):7539-50. PubMed ID: 22031094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated RNA expression of long non‑coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma.
    Yan Y; Han J; Li Z; Yang H; Sui Y; Wang M
    Mol Med Rep; 2016 Jun; 13(6):5125-31. PubMed ID: 27122348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ASPM Predicts Poor Clinical Outcome and Promotes Tumorigenesis for Diffuse Large B-cell Lymphoma.
    Wu J; He Z; Zhu Y; Jiang C; Deng Y; Wei B
    Curr Cancer Drug Targets; 2021; 21(1):80-89. PubMed ID: 32933462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PLAGL2 Promotes the Proliferation and Migration of Diffuse Large B-cell Lymphoma Cells via Wnt/β-catenin Pathway.
    Jin W; Wang X
    Ann Clin Lab Sci; 2022 May; 52(3):359-366. PubMed ID: 35777795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5/miR-27b-3p/MET axis.
    Hu L; Zhao J; Liu Y; Liu X; Lu Q; Zeng Z; Zhu L; Tong X; Xu Q
    Int J Med Sci; 2020; 17(17):2735-2743. PubMed ID: 33162801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown MTDH Inhibits Glioma Proliferation and Migration and Promotes Apoptosis by Downregulating MYBL2.
    Fu J; Peng J; Tu G
    Mediators Inflamm; 2022; 2022():1706787. PubMed ID: 36133745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment and characterization of MTDH knockdown by artificial MicroRNA interference - functions as a potential tumor suppressor in breast cancer.
    Wang S; Shu JZ; Cai Y; Bao Z; Liang QM
    Asian Pac J Cancer Prev; 2012; 13(6):2813-8. PubMed ID: 22938464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A circular RNA from
    Hu Y; Zhao Y; Shi C; Ren P; Wei B; Guo Y; Ma J
    Aging (Albany NY); 2019 Oct; 11(19):8068-8084. PubMed ID: 31631067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. microRNA‑196a‑3p inhibits cell proliferation and promotes cell apoptosis by targeting ADP ribosylation factor 4 in diffuse large B‑cell lymphoma.
    Fu J; Lou X; Wan S; Zhao X; Chen Z; Zhu M; Guo L; Wu D; Wang S
    Oncol Rep; 2021 Feb; 45(2):764-775. PubMed ID: 33416178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma.
    Shen M; Zhang Y; Tang L; Fu Q; Zhang J; Xu Y; Zeng H; Li Y
    BMC Cancer; 2023 Oct; 23(1):978. PubMed ID: 37833632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.